Beta Bionics, Inc. (BBNX) Gains from Sales and Divestitures (2025 - 2026)

Beta Bionics (BBNX) posted Gains from Sales and Divestitures of $72616.0 for Q1 2026, down 73.68% sequentially from $275919.0 in Q4 2025.

Beta Bionics, Inc. (BBNX) Gains from Sales and Divestitures (2025 - 2026) Analysis & Trends

Beta Bionics (BBNX) has 2 years of Gains from Sales and Divestitures data on file, last reported at $72616.0 in Q1 2026.

Quarterly Gains from Sales and Divestitures changed N/A year-over-year to $72616.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $72616.0 (changed N/A YoY) and the FY2025 annual result came in at $275919.0, changed N/A from the prior year.
Gains from Sales and Divestitures declined to $72616.0 in Q1 2026 per BBNX's latest filing, from $275919.0 in the prior quarter.
The five-year high for Gains from Sales and Divestitures was $275919.0 in Q4 2025, with the low at $72616.0 in Q1 2026.

Download Data